Jorge Luis Poo

Medicine · Health Sciences

19h-index1.2kcitations66works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(30), Liver Disease and Transplantation(27), Hepatitis C virus research(11), Liver Diseases and Immunity(8), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(7)

Publications66 total

Pirfenidone as a Pleiotropic Antifibrotic Agent in Metabolic Steatohepatitis: From Mechanisms to Clinical Evidence
Archives of Medical Research·2026
HCV patients with residual fibrosis after DAA treatment re-establish their epigenetic signature after prolonged-release pirfenidone: MINERVA study
Clinical Epigenetics·2025· 2 citedOpen Access
Pirfenidone in post-COVID-19 pulmonary fibrosis
European Respiratory Journal·2025Open Access
Noninvasive Evaluation of Prolonged‐Release Pirfenidone in Compensated Liver Cirrhosis. <scp>ODISEA</scp> Study, a Randomised Trial
Liver International·2025· 6 citedOpen Access
Prolonged release pirfenidone restores miRNA expression and CpG island methylation in patients with HCV sustained virological response and residual liver fibrosis
Annals of Hepatology·2025Open Access
Human very small embryonic-like (hVSEL) stem cells and the reversal of advanced liver fibrosis
Journal of Stem Cell Research & Therapeutics·2025Open Access
P-26 EPIGENETIC MARKS IN PATIENTS WITH SUSTAINED VIRAL RESPONSE TO HCV AND RESIDUAL LIVER FIBROSIS ARE RESTORED BY PROLONGED-RELEASE PIRFENIDONE
Annals of Hepatology·2024Open Access
FRI-029 Shear wave elastography predicts risk categories in patients with cirrhosis, PANDORA study
Journal of Hepatology·2024
Prolonged-release pirfenidone in patients with compensated cirrhosis. Final results of the multicenter study ODISEA, controlled against placebo, plus standardized care_2023
Annals of Hepatology·2024· 1 citedOpen Access
Prolonged release pirfenidone pharmacokinetics is modified in cirrhosis GENESIS study
Biomedicine & Pharmacotherapy·2023· 5 citedOpen Access
Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy
Respiratory Medicine·2023· 14 citedOpen Access
Evaluación de la concentración de azufre en dietas de bovinos en engorde a corral del sur de Córdoba y Santa Fe
Revista Veterinaria·2021· 1 citedOpen Access
Effect of Prolonged-Release Pirfenidone on Renal Function in Septic Acute Kidney Injury Patients: A Double-Blind Placebo-Controlled Clinical Trial
International Journal of Nephrology·2021· 8 citedOpen Access
Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study
Hepatology International·2020· 57 citedOpen Access
Pharmacokinetics of the Antifibrotic Drug Pirfenidone in Child Pugh A and B Cirrhotic Patients Compared to Healthy Age-Matched Controls
Journal of Hepatology·2016· 3 cited
Challenges in treating liver fibrosis
Annals of Hepatology·2014Open Access
[Epidemiology, physiopathology and diagnosis of pulmonary hypertension in hepatic (PH) cirrhosis].
PubMed·2012· 6 cited
Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City
The Pediatric Infectious Disease Journal·2010· 107 cited
Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: An open-label, randomized, two-period crossover comparison in healthy mexican volunteers
Clinical Therapeutics·2009· 18 cited
295 Final Results of the EPIC3 Cirrhosis Maintenance Trial: Pegintron Maintenance Therapy in Cirrhotic (METAVIR F4) HCV Patients, Who Failed to Respond to Interferon/Ribavirn (IR) Therapy:
Gastroenterology·2009· 6 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Misael Uribe(15), Christophe Gaudin(9), Didier Lebrec(9), Alain Braillon(8), Linda E. Muñoz‐Espinosa(6), Richard Moreau(6), J.F. Sánchez-Ávila(4), Julieta Góngora(4), Graciela Tapia(4), Juan Armendáriz‐Borunda(4), Mario González-de la Parra(4), Juan Ramón Aguilar-Ramírez(3), Beatriz Castañeda(3), Javier Lizardi(3), Aldo Torre(3), Laura Cisneros(3), Reina Rosas-Romero(3), Ana C. Montemayor(3), Fernando Isoard(3), Arturo Panduro(3)